Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice.
about
Mouse models of dengue virus infection for vaccine testingTackling dengue fever: Current status and challengesMouse models to study dengue virus immunology and pathogenesisUnderstanding the dengue viruses and progress towards their controlRational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaquesA rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primatesEfficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in MiceFlaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.Current progress in dengue vaccinesDengue: challenges for policy makers and vaccine developers.Dengue vaccines: recent developments, ongoing challenges and current candidates.Adaptation of enterovirus 71 to adult interferon deficient mice.Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial.CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate.Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 studyChallenges in reducing dengue burden; diagnostics, control measures and vaccines.A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone.Vaccines licensed and in clinical trials for the prevention of dengue.Development of Peptide Vaccines in Dengue.Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties.Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.Zika virus like particles elicit protective antibodies in mice.
P2860
Q24276139-D7A01C99-6E8C-4FB8-9206-E547FCEF8FFFQ24288867-85F040E0-58AF-4F9D-ADB5-E504D16BF6B9Q27010151-97FA999C-4F80-4269-A7E6-92DADCB582C2Q27011587-00484400-D158-4B41-85A6-B48290C68671Q27334248-3A48BCAF-1B38-42B7-8DC7-BB91E9E05F5BQ28241909-6899F07E-A8F9-4B8F-85F3-AE5BC84874E7Q28606867-BD613F4C-1F36-449E-9A75-F5664D673CE8Q30857727-7EEF773B-4857-4E2C-9E73-B98035070F00Q33408300-26090CB1-9154-4FA7-98BF-BBDB29FE3C8EQ33624327-3DD9B05B-1CA2-4C3D-8604-3E2C56604264Q34367194-A06A5A14-B22C-4BB7-8E68-71D0498FAC40Q34635242-BC2FEC05-E197-42D0-80DD-FAED66FA74C1Q34759091-4745DFA4-6D97-486B-9A0F-28435F96FAE6Q35105926-9099351C-930D-41B5-B3D8-9A94FEA28BD9Q36024479-FD29BA53-4DC6-434B-9DE6-EDD10E8FE371Q36208591-2415365C-55F2-41F3-8993-696DA2ED96C4Q36288109-A70179A0-CE09-480D-A6F2-671D0FC31199Q38140035-BB7F2C42-0B40-4885-A34E-C55DCFF0A4CAQ38658737-331DAB17-11A1-4761-9DCD-A5A4AFEFE7A6Q39172722-A15659BE-0967-4226-BBD7-F2486747595CQ40038715-8F48E515-317A-4B81-93B5-9D47B35BE543Q40190331-6282BF70-F5B4-4E1D-9CE5-382506454B33Q47265866-DDE02256-0D2C-4054-A1AD-CD9F91F20D5FQ47562022-65FF7E24-C629-43D0-BF4E-E6FA125BA8ACQ48105726-B519EB0F-4E7D-42E9-8BE4-FEEE3D655B25
P2860
Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Immunogenicity and efficacy of ...... terferon-deficient AG129 mice.
@en
type
label
Immunogenicity and efficacy of ...... terferon-deficient AG129 mice.
@en
prefLabel
Immunogenicity and efficacy of ...... terferon-deficient AG129 mice.
@en
P2093
P2860
P1433
P1476
Immunogenicity and efficacy of ...... terferon-deficient AG129 mice.
@en
P2093
Charalambos D Partidos
Claire Y-H Huang
John J Arguello
Joseph N Brewoo
Richard M Kinney
Shawn J Silengo
Tim D Powell
P2860
P304
P356
10.1016/J.VACCINE.2011.11.072
P407
P577
2011-12-13T00:00:00Z